Oct 2011

Home >> Clinical Trials News Archive >> 2011 >> Oct 2011
Professor Daniel Shechtman from Haifa's Technion wins Israel's 10th Nobel for his discovery of unusual patterns in atoms.

Over the last 10 years, the top nine global CROs have more than doubled their workforce, which now exceeds 72,000 employees, and their revenues have increased at a compound annualized rate of 11% as they increasingly play a larger and more integral role in the drug development infrastructure.
 
Quintiles has agreed to buy Advion BioServices, a 19-year-old bioanalytical lab that recently penned a strategic partnership with Eli Lilly.

Middle East region poised for clinical trials growth. With sponsors and CROs still on the hunt for emerging markets rife with treatment-naive patients and good infrastructure, interest in the Middle East is increasing.
 
Integrated CRO alliances growing but poorly executed. Results from a new CenterWatch survey show contract research organizations (CROs) generally believe that while the prevalence of integrated alliances with sponsor companies will grow in the next three to five years, many sponsors fall short when managing these more sophisticated relationships.